Cerebral Blood Flow and Marrow Diffusion Alterations in Children with Sickle Cell Anemia after Bone Marrow Transplantation and Transfusion

References

1. 1.↵
   Sickle Cell Disease (SCD). Centers for Disease Control and Prevention. Updated August 31, 2016. https://www.cdc.gov/ncbddd/sicklecell/data.html. Accessed September 14, 2018..
2. 2.↵
   2. Elias EJ,
   3. Liao JH,
   4. Jara H, et al

   . Quantitative MRI analysis of craniofacial bone marrow in patients with sickle cell disease. AJNR Am J Neuroradiol 2013;34:622–27 doi:10.3174/ajnr.A3240 pmid:22878006

   Abstract/FREE Full Text
3. 3.↵
   2. Saito N,
   3. Nadgir RN,
   4. Flower EN, et al

   . Clinical and radiologic manifestations of sickle cell disease in the head and neck. Radiographics 2010;30:1021–34 doi:10.1148/rg.304095171 pmid:20631366

   CrossRefPubMed
4. 4.↵
   2. Park S,
   3. Kwack KS,
   4. Chung NS, et al

   . Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging of focal vertebral bone marrow lesions: initial experience of the differentiation of nodular hyperplastic hematopoietic bone marrow from malignant lesions. Skeletal Radiol 2017;46:675–83 doi:10.1007/s00256-017-2603-z pmid:28265697

   CrossRefPubMed
5. 5.↵
   2. Kosinski PD,
   3. Croal PL,
   4. Leung J, et al

   . The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitative magnetic resonance imaging study. Br J Haematol 2017;176:280–87 doi:10.1111/bjh.14424 pmid:27905100

   CrossRefPubMed
6. 6.↵
   2. Arkuszewski M,
   3. Krejza J,
   4. Chen R, et al

   . Sickle cell anemia: reference values of cerebral blood flow determined by continuous arterial spin labeling MRI. Neuroradiol J 2013;26:191–200 doi:10.1177/197140091302600209 pmid:23859242

   CrossRefPubMed
7. 7.↵
   2. Alsop DC,
   3. Detre JA,
   4. Golay X, et al

   . Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015;73:102–16 doi:10.1002/mrm.25197 pmid:24715426

   CrossRefPubMed
8. 8.↵
   2. Grade M,
   3. Hernandez Tamames JA,
   4. Pizzini FB, et al

   . A neuroradiologist's guide to arterial spin labeling MRI in clinical practice. Neuroradiology 2015;57:1181–202 doi:10.1007/s00234-015-1571-z pmid:26351201

   CrossRefPubMed
9. 9.↵
   2. Deibler AR,
   3. Pollock JM,
   4. Kraft RA, et al

   . Arterial spin-labeling in routine clinical practice, Part 1: techniques and artifacts. AJNR Am J Neuroradiol 2008;29:1228–34 doi:10.3174/ajnr.A1030 pmid:18372417

   Abstract/FREE Full Text
10. 10.↵
    2. Deibler AR,
    3. Pollock JM,
    4. Kraft RA, et al

    . Arterial spin-labeling in routine clinical practice, Part 2: hypoperfusion patterns. AJNR Am J Neuroradiol 2008;29:1235–41 doi:10.3174/ajnr.A1033 pmid:18356467

    Abstract/FREE Full Text
11. 11.↵
    2. Deibler AR,
    3. Pollock JM,
    4. Kraft RA, et al

    . Arterial spin-labeling in routine clinical practice, Part 3: hyperperfusion patterns. AJNR Am J Neuroradiol 2008;29:1428–35 doi:10.3174/ajnr.A1034 pmid:18356466

    Abstract/FREE Full Text
12. 12.↵
    2. Hales PW,
    3. Kirkham FJ,
    4. Clark CA

    . A general model to calculate the spin-lattice (T1) relaxation time of blood, accounting for haematocrit, oxygen saturation and magnetic field strength. J Cereb Blood Flow Metab 2016;36:370–74 doi:10.1177/0271678X15605856 pmid:26661147

    CrossRefPubMed
13. 13.↵
    2. Gluckman E,
    3. Cappelli B,
    4. Bernaudin F, et al

    ; Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood 2017;129:1548–56 doi:10.1182/blood-2016-10-745711 pmid:27965196

    Abstract/FREE Full Text
14. 14.↵
    2. Shenoy S,
    3. Eapen M,
    4. Panepinto JA, et al

    . A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood 2016;128:2561–67 doi:10.1182/blood-2016-05-715870 pmid:27625358

    Abstract/FREE Full Text
15. 15.↵
    2. Dalle JH

    . Hematopoietic stem cell transplantation in SCD. C R Biol 2013;336:148–51 doi:10.1016/j.crvi.2012.09.004 pmid:23643397

    CrossRefPubMed
16. 16.↵
    2. Walters MC

    . Update of hematopoietic cell transplantation for sickle cell disease. Curr Opin Hematol 2015;22:227–33 doi:10.1097/MOH.0000000000000136 pmid:25767957

    CrossRefPubMed
17. 17.↵
    2. Fitzhugh CD,
    3. Abraham AA,
    4. Tisdale JF, et al

    . Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions. Hematol Oncol Clin North Am 2014;28:1171–85 doi:10.1016/j.hoc.2014.08.014 pmid:25459186

    CrossRefPubMed
18. 18.↵
    2. Angelucci E,
    3. Matthes-Martin S,
    4. Baronciani D, et al

    ; EBMT Inborn Error and EBMT Paediatric Working Parties. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica 2014;99:811–20 doi:10.3324/haematol.2013.099747 pmid:24790059

    Abstract/FREE Full Text
19. 19.↵
    2. Dedeken L,
    3. Lê PQ,
    4. Azzi N, et al

    . Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients. Br J Haematol 2014;165:402–08 doi:10.1111/bjh.12737 pmid:24433465

    CrossRefPubMed
20. 20.↵
    2. Gluckman E

    . Allogenic transplantation strategies including haploidentical transplantation in sickle cell disease. Hematol Am Soc Hematol Educ Program 2013;2013:370–76 doi:10.1182/asheducation-2013.1.370 pmid:24319206

    Abstract/FREE Full Text
21. 21.↵
    2. Wintermark M,
    3. Lepori D,
    4. Cotting J, et al

    . Brain perfusion in children: evolution with age assessed by quantitative perfusion computed tomography. Pediatrics 2004;113:1642–52 doi:10.1542/peds.113.6.1642 pmid:15173485

    Abstract/FREE Full Text
22. 22.↵
    2. Goetti R,
    3. O'Gorman R,
    4. Khan N, et al

    . Arterial spin labeling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI. Neuroradiology 2013;55:639–47 doi:10.1007/s00234-013-1155-8 pmid:23404242

    CrossRefPubMed
23. 23.↵
    2. Guilliams KP,
    3. Fields ME,
    4. Ragan DK, et al

    . Red cell exchange transfusions lower cerebral blood flow and oxygen extraction fraction in pediatric sickle cell anemia. Blood 2018;131:1012–21 doi:10.1182/blood-2017-06-789842 pmid:29255068

    Abstract/FREE Full Text
24. 24.↵
    2. Wu WC,
    3. St Lawrence KS,
    4. Licht DJ, et al

    . Quantification issues in arterial spin labeling perfusion magnetic resonance imaging. Top Magn Reson Imaging 2010;21:65–73. doi:10.1097/RMR.0b013e31821e570a pmid:21613872

    CrossRefPubMed
25. 25.↵
    2. Václavů L,
    3. van der Land V,
    4. Heijtel DF, et al

    . In vivo T1 of blood measurements in children with sickle cell disease improve cerebral blood flow quantification from arterial spin-labeling MRI. AJNR Am J Neuroradiol 2016;37:1727–32 doi:10.3174/ajnr.A4793 pmid:27231223

    Abstract/FREE Full Text
26. 26.↵
    2. Hales PW,
    3. Kawadler JM,
    4. Aylett SE, et al

    . Arterial spin labeling characterization of cerebral perfusion during normal maturation from late childhood into adulthood: normal ‘reference range’ values and their use in clinical studies. J Cereb Blood Flow Metab 2014;34:776–84 doi:10.1038/jcbfm.2014.17 pmid:24496173

    CrossRefPubMed
27. 27.↵
    2. Wang J,
    3. Licht DJ

    . Pediatric perfusion MR imaging using arterial spin labeling. Neuroimaging Clin N Am 2006;16:149–67, ix pmid:16543090

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Helton KJ,
    3. Paydar A,
    4. Glass J, et al

    . Arterial spin-labeled perfusion combined with segmentation techniques to evaluate cerebral blood flow in white and gray matter of children with sickle cell anemia. Pediatr Blood Cancer 2009;52:85–91 doi:10.1002/pbc.21745 pmid:18937311

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Dallas MH,
    3. Triplett B,
    4. Shook DR, et al

    . Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant 2013;19:820–30 doi:10.1016/j.bbmt.2013.02.010 pmid:23416852

    CrossRefPubMed
30. 30.↵
    2. Bush A,
    3. Chai Y,
    4. Choi SY, et al

    . Pseudo continuous arterial spin labeling quantification in anemic subjects with hyperemic cerebral blood flow. Magn Reson Imaging 2018;47:137–46 doi:10.1016/j.mri.2017.12.011 pmid:29229306

    CrossRefPubMed
31. 31.↵
    2. Gevers S,
    3. Nederveen AJ,
    4. Fijnvandraat K, et al

    . Arterial spin labeling measurement of cerebral perfusion in children with sickle cell disease. J Magn Reson Imaging 2012;35:779–87 doi:10.1002/jmri.23505 pmid:22095695

    CrossRefPubMed